Rohto PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Rohto PharmaceuticalLtd has a total shareholder equity of ¥247.0B and total debt of ¥10.5B, which brings its debt-to-equity ratio to 4.2%. Its total assets and total liabilities are ¥346.2B and ¥99.1B respectively. Rohto PharmaceuticalLtd's EBIT is ¥40.2B making its interest coverage ratio -22.2. It has cash and short-term investments of ¥89.2B.
Key information
4.2%
Debt to equity ratio
JP¥10.49b
Debt
Interest coverage ratio | -22.2x |
Cash | JP¥89.21b |
Equity | JP¥247.03b |
Total liabilities | JP¥99.14b |
Total assets | JP¥346.18b |
Recent financial health updates
Recent updates
Calculating The Fair Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)
Jun 23Unpleasant Surprises Could Be In Store For Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Shares
Jun 10Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward
May 14These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely
Apr 03Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching
Mar 21Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year
Mar 07Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)
Feb 26Financial Position Analysis
Short Term Liabilities: 4527's short term assets (¥214.8B) exceed its short term liabilities (¥87.1B).
Long Term Liabilities: 4527's short term assets (¥214.8B) exceed its long term liabilities (¥12.1B).
Debt to Equity History and Analysis
Debt Level: 4527 has more cash than its total debt.
Reducing Debt: 4527's debt to equity ratio has increased from 3.9% to 4.2% over the past 5 years.
Debt Coverage: 4527's debt is well covered by operating cash flow (326.3%).
Interest Coverage: 4527 earns more interest than it pays, so coverage of interest payments is not a concern.